In this study, the role of
interleukin (IL)-12 on the antimetastatic effect of
Z-100 was investigated using wild-type C57BL/6 mice or
IL-12p40 knockout (IL-12p40 KO) mice inoculated with highly metastatic B16F10
melanoma. When C57BL/6 mice were inoculated with B16F10
melanoma (2x10(5) cells/mouse i.v.),
Z-100 (10 mg/kg i.p.) significantly suppressed the pulmonary
metastasis of B16F10
melanoma 14 d after
tumor inoculation. On the other hand, the antimetastatic effect of
Z-100 was not observed in
IL-12p40 KO mice inoculated with B16F10
melanoma. These results indicate that
IL-12 is essentially required for the appearance of the antimetastatic effect of
Z-100. Since helper T (Th) 2 cell responses have been reported to have a role in
tumor metastasis, the regulatory effect of
Z-100 on the immune balance of Th1/Th2 cell responses was investigated. In both C57BL/6 mice and
IL-12p40 KO mice bearing B16F10
melanoma, Th1
cytokine production (IL-2, interferon-gamma) was significantly suppressed as compared with those in normal mice. On the other hand, Th2
cytokine production (IL-4, IL-10) in these mice was increased. The administration of
Z-100 (10 mg/kg i.p.) in C57BL/6 mice bearing B16F10
melanoma improved the balance of Th1/Th2 cell responses from the Th2-dominant state to the normal state. However, the improvement of Th1/Th2 cell responses by
Z-100 was not observed in
IL-12p40 KO mice bearing the same
tumors. In addition,
Z-100 significantly increased
IL-12 production by macrophages in a concentration-dependent manner, while
Z-100 significantly decreased
IL-10 production by these cells in vitro. These results suggested that up-regulation of
IL-12 production and down-regulation of
IL-10 production by
Z-100 are related to the improvement of Th1/Th2 cell responses from the Th2-dominant state to the normal state, which resulted in suppression of
tumor metastasis.